-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ultragenyx Pharmaceutical Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2017 to Q2 2024.
- Ultragenyx Pharmaceutical Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 86.6M shares, a 22.1% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 73.5M shares, a 5.19% increase from 2022.
- Ultragenyx Pharmaceutical Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 69.9M shares, a 3.13% increase from 2021.
- Ultragenyx Pharmaceutical Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 67.8M shares, a 11.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)